Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.37
0.0951.80%
Last update: Dec 15, 11:13 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Altimmune (ALT) stock?
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Who are Altimmune (ALT) competitors?
Other companies in Altimmune’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Monopar Therapeutics Inc (NASDAQ:MNPR), Prothena Corp PLC (NASDAQ:PRTA) and ADC Therapeutics SA (NYSE:ADCT).
What is the forecast, or price target, for Altimmune (ALT) stock?
Altimmune has a consensus price target of $18.27.
What is the current price for Altimmune (ALT)?
The stock price for Altimmune (NASDAQ: ALT) is $5.365 last updated December 15, 2025 at 11:13 AM EST.
Does Altimmune (ALT) pay a dividend?
There are no upcoming dividends for Altimmune.
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune does not have any upcoming earnings scheduled.
Is Altimmune (ALT) going to split?
There is no upcoming split for Altimmune.
What sector and industry does Altimmune (ALT) operate in?
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
